We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDC icon
1476
Teradata
TDC
$2.56B
$3.29M ﹤0.01%
91,858
-21,012
-19% -$819K
OSK icon
1477
Oshkosh
OSK
$9.54B
$3.27M ﹤0.01%
39,150
-9,900
-20% -$779K
PMM
1478
Franklin Managed Municipal Income Trust
PMM
$272M
$3.27M ﹤0.01%
427,947
+49,697
+13% +$375K
AOD
1479
abrdn Total Dynamic Dividend Fund
AOD
$1.13B
$3.26M ﹤0.01%
391,405
-46,845
-11% -$387K
DFNL icon
1480
Davis Select Financial ETF
DFNL
$491M
$3.25M ﹤0.01%
139,436
+780
+0.6% +$17.9K
CAE icon
1481
CAE Inc. Common Shares
CAE
$8.79B
$3.23M ﹤0.01%
120,329
+21,258
+21% +$519K
AIN icon
1482
Albany International
AIN
$1.73B
$3.22M ﹤0.01%
38,885
+3,216
+9% +$241K
RNST icon
1483
Renasant Corp
RNST
$3.89B
$3.22M ﹤0.01%
89,537
+2,124
+2% +$74.7K
GCOW icon
1484
Pacer Global Cash Cows Dividend ETF
GCOW
$3.48B
$3.22M ﹤0.01%
105,384
+60,691
+136% +$1.85M
IART icon
1485
Integra LifeSciences
IART
$1.34B
$3.19M ﹤0.01%
57,105
+415
+0.7% +$21.4K
JPEM icon
1486
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$395M
$3.19M ﹤0.01%
57,285
+6,639
+13% +$361K
EXEL icon
1487
Exelixis
EXEL
$13.2B
$3.18M ﹤0.01%
148,764
-197,851
-57% -$4.15M
RMD icon
1488
ResMed
RMD
$31.7B
$3.18M ﹤0.01%
26,034
+18,816
+261% +$2.08M
EIM
1489
Eaton Vance Municipal Bond Fund
EIM
$499M
$3.17M ﹤0.01%
255,275
-22,008
-8% -$274K
FXN icon
1490
First Trust Energy AlphaDEX Fund
FXN
$380M
$3.17M ﹤0.01%
275,790
-40,352
-13% -$487K
IPAY icon
1491
Amplify Mobile Payments ETF
IPAY
$182M
$3.17M ﹤0.01%
67,496
+26,952
+66% +$1.2M
KRC icon
1492
Kilroy Realty
KRC
$4.33B
$3.16M ﹤0.01%
42,820
-1,837
-4% -$140K
ERC
1493
Allspring Multi-Sector Income Fund
ERC
$261M
$3.15M ﹤0.01%
251,251
+33,405
+15% +$413K
HELE icon
1494
Helen of Troy
HELE
$661M
$3.15M ﹤0.01%
24,108
+67
+0.3% +$8.77K
IQI icon
1495
Invesco Quality Municipal Securities
IQI
$532M
$3.14M ﹤0.01%
253,009
-9,711
-4% -$118K
ACV
1496
Virtus Diversified Income & Convertible Fund
ACV
$286M
$3.14M ﹤0.01%
134,439
-7,217
-5% -$167K
VLY icon
1497
Valley National Bancorp
VLY
$8.06B
$3.14M ﹤0.01%
291,227
+42,607
+17% +$437K
TGI
1498
DELISTED
Triumph Group
TGI
$3.13M ﹤0.01%
136,776
+375
+0.3% +$8.06K
CQQQ icon
1499
Invesco China Technology ETF
CQQQ
$3.3B
$3.13M ﹤0.01%
69,010
+26,376
+62% +$1.24M
MDC
1500
DELISTED
M.D.C. Holdings, Inc.
MDC
$3.12M ﹤0.01%
102,865
-6,365
-6% -$187K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.